These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 24531224)

  • 61. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: Profile of clinical candidate (2R,3S,5R)-2- (2,5-difluorophenyl)-5-(4,6-dihydropyrrolo [3,4-c]pyrazol-5-(1H)-yl)tetrahydro-2H-pyran-3-amine (23) [corrected].
    Biftu T; Qian X; Chen P; Feng D; Scapin G; Gao YD; Cox J; Roy RS; Eiermann G; He H; Lyons K; Salituro G; Patel S; Petrov A; Xu F; Xu SS; Zhang B; Caldwell C; Wu JK; Lyons K; Weber AE
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5361-6. PubMed ID: 23972441
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design and Synthesis.
    Khalaf RA; Masalha D; Sabbah D
    Curr Comput Aided Drug Des; 2020; 16(3):295-307. PubMed ID: 30526469
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis, nitric oxide release, and dipeptidyl peptidase-4 inhibition of sitagliptin derivatives as new multifunctional antidiabetic agents.
    Xie Y; Shao L; Wang Q; Bai Y; Chen Z; Li N; Xu Y; Li Y; Yang G; Bian X
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3731-3735. PubMed ID: 30343953
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-IV inhibitors.
    Jadav P; Bahekar R; Shah SR; Patel D; Joharapurkar A; Jain M; Sairam KV; Singh PK
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1918-22. PubMed ID: 24675378
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design and synthesis of DPP-IV inhibitors lacking the electrophilic nitrile group.
    Kondo T; Nekado T; Sugimoto I; Ochi K; Takai S; Kinoshita A; Hatayama A; Yamamoto S; Kishikawa K; Nakai H; Toda M
    Bioorg Med Chem; 2008 Feb; 16(4):1613-31. PubMed ID: 18039579
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitors.
    Meng W; Brigance RP; Chao HJ; Fura A; Harrity T; Marcinkeviciene J; O'Connor SP; Tamura JK; Xie D; Zhang Y; Klei HE; Kish K; Weigelt CA; Turdi H; Wang A; Zahler R; Kirby MS; Hamann LG
    J Med Chem; 2010 Aug; 53(15):5620-8. PubMed ID: 20684603
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vildagliptin-Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9-Specific Lead.
    Benramdane S; De Loose J; Beyens O; Van Rymenant Y; Vliegen G; Augustyns K; De Winter H; De Meester I; Van der Veken P
    ChemMedChem; 2022 Aug; 17(15):e202200097. PubMed ID: 35760756
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors.
    Wallace MB; Feng J; Zhang Z; Skene RJ; Shi L; Caster CL; Kassel DB; Xu R; Gwaltney SL
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2362-7. PubMed ID: 18346892
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rapid generation of a novel DPP-4 inhibitor with long-acting properties: SAR study and PK/PD evaluation.
    Xie H; Zeng S; He Y; Zhang G; Yu P; Zhong G; Xu H; Yang L; Wang S; Zhao X; Hu W
    Eur J Med Chem; 2017 Dec; 141():519-529. PubMed ID: 29078995
    [TBL] [Abstract][Full Text] [Related]  

  • 71. cis-2,5-dicyanopyrrolidine inhibitors of dipeptidyl peptidase IV: synthesis and in vitro, in vivo, and X-ray crystallographic characterization.
    Wright SW; Ammirati MJ; Andrews KM; Brodeur AM; Danley DE; Doran SD; Lillquist JS; McClure LD; McPherson RK; Orena SJ; Parker JC; Polivkova J; Qiu X; Soeller WC; Soglia CB; Treadway JL; VanVolkenburg MA; Wang H; Wilder DC; Olson TV
    J Med Chem; 2006 Jun; 49(11):3068-76. PubMed ID: 16722626
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Surrogating and redirection of pyrazolo[1,5-a]pyrimidin-7(4H)-one core, a novel class of potent and selective DPP-4 inhibitors.
    Deng X; Shen J; Zhu H; Xiao J; Sun R; Xie F; Lam C; Wang J; Qiao Y; Tavallaie MS; Hu Y; Du Y; Li J; Fu L; Jiang F
    Bioorg Med Chem; 2018 Feb; 26(4):903-912. PubMed ID: 29373269
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Design, synthesis and in vitro activity of glycinamide-bearing compounds as DPP-IV inhibitors].
    Han B; Huan Y; Lin ZY; Li P; Shen ZF; Yin DL; Huang HH
    Yao Xue Xue Bao; 2010 Nov; 45(11):1379-84. PubMed ID: 21361038
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Discovery of potent dipeptidyl peptidase IV inhibitors derived from β-aminoamides bearing substituted [1,2,3]-triazolopiperidines for the treatment of type 2 diabetes.
    Shan Z; Peng M; Fan H; Lu Q; Lu P; Zhao C; Chen Y
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1731-5. PubMed ID: 21334204
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Scaffold-hopping from xanthines to tricyclic guanines: A case study of dipeptidyl peptidase 4 (DPP4) inhibitors.
    Pissarnitski DA; Zhao Z; Cole D; Wu WL; Domalski M; Clader JW; Scapin G; Voigt J; Soriano A; Kelly T; Powles MA; Yao Z; Burnett DA
    Bioorg Med Chem; 2016 Nov; 24(21):5534-5545. PubMed ID: 27670099
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore.
    Nishio Y; Kimura H; Tosaki S; Sugaru E; Sakai M; Horiguchi M; Masui Y; Ono M; Nakagawa T; Nakahira H
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7246-9. PubMed ID: 21074430
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Integrated Protocol to Design Potential Inhibitors of Dipeptidyl Peptidase- 4 (DPP-4).
    Pantaleão SQ; Philot EA; de Oliveira Almeida M; Lima AN; de Sairre MI; Scott AL; Honorio KM
    Curr Top Med Chem; 2020; 20(3):209-226. PubMed ID: 31878857
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and evaluation of camphor and cytisine-based cyanopyrrolidines as DPP-IV inhibitors for the treatment of type 2 diabetes mellitus.
    Kuranov SO; Tsypysheva IP; Khvostov MV; Zainullina LF; Borisevich SS; Vakhitova YV; Luzina OA; Salakhutdinov NF
    Bioorg Med Chem; 2018 Aug; 26(15):4402-4409. PubMed ID: 30056037
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dipeptidyl peptidase IV inhibitors: a new paradigm in type 2 diabetes treatment.
    Janardhan S; Sastry GN
    Curr Drug Targets; 2014 Jun; 15(6):600-21. PubMed ID: 24611684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.